Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model
Diabetes, Obesity and Metabolism · 2026-09 · 28 (9) · 7834-7848
DOI: 10.1111/dom.70972 ↗At a glance
Journal article in Diabetes, Obesity and Metabolism, published online on 2026-06-09. Written by Yu Liao and 5 co-authors. Institution: Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Major MEDLINE topics: Gastrointestinal Microbiome, Bifidobacterium breve, Obesity, Dysbiosis. 57 references. The full text is freely available in PubMed Central. Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation Promotion Project within Renji Hospital, Shanghai Jiao Tong University School of Medicine.
Abstract (original language)
Aim
This study aimed to evaluate the modulatory effects of Bifidobacterium breve BBr60 on gut microbiota dysbiosis and metabolic abnormalities in a high‐fat diet (HFD) ‐induced obese mouse model.
Methods
Thirty mice aged 6 weeks were divided into a normal diet group (CTL), an HFD group, and a BBr60 intervention group (HFD + BBr60). During 8 weeks, the food intake and body weight of the mice were monitored. Subsequently, an oral glucose tolerance test (OGTT) was conducted, and fasting insulin levels, lipid profiles, and the gut microbiota composition were determined. Liver lesions, inflammation levels, and tight junction protein expression were examined using Oil Red O staining, haematoxylin and eosin staining, and reverse transcription polymerase chain reaction analysis, respectively. 16s rRNA high‐throughput sequencing techniques were used to investigate the diversity and richness of the gut microbiota.
Results
BBr60 not only ameliorated HFD‐induced metabolic disorders, including weight gain (body weight, p < 0.001), hyperglycaemia (FBG, p < 0.001), insulin resistance (HOMA‐IR, p = 0.002), dyslipidaemia (TC, p < 0.001), and liver steatosis, but also mitigated systemic inflammation and impaired intestinal permeability. Furthermore, BBr60 reversed gut microbiota dysbiosis, as evidenced by a significant reduction in the relative abundance of opportunistic pathogens such as Duncaniella, Allobaculum , and Parasutterella while increasing beneficial bacteria such as Clostridium cluster XIVa, Limosilactobacillus , and Bifidobacterium . Time‐dynamic analyses showed that BBr60 regulated the relative abundance of the gut microbiota and improved HFD‐induced dysbiosis of the gut microbiota.
Conclusion
BBr60 significantly ameliorated glucose and lipid metabolic disorders and gut microbiota dysbiosis in an HFD‐induced obese mouse model, and these effects were associated with changes in gut microbiota composition, suggesting its potential as a therapeutic intervention for obesity‐related metabolic abnormalities.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Life Sciences and Technology, Tongji University, Shanghai, China.
ORCID profiles: Yu Liao, Yi-Cheng Qi, Jing Ma
Funding
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation Promotion Project within Renji Hospital, Shanghai Jiao Tong University School of Medicine
Cite
APA
Liao, Y., Yuan, X., Qin, A. Q., Qi, Y. C., Shan, C., & Ma, J. (2026). Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model. Diabetes, Obesity and Metabolism, 28(9), 7834-7848. https://doi.org/10.1111/dom.70972
Vancouver
Liao Y, Yuan X, Qin AQ, Qi YC, Shan C, Ma J. Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model. Diabetes, Obesity and Metabolism. 2026;28(9):7834-7848. doi:10.1111/dom.70972
BibTeX
@article{Liao2026,
author = {Liao, Yu and Yuan, Xun and Qin, An-Qi and Qi, Yi-Cheng and Shan, Chang and Ma, Jing},
title = {Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {9},
pages = {7834--7848},
doi = {10.1111/dom.70972}
}
EUVIMED